November 27, 2017 Kuo, MD, MBA, Adeona’s CEO.. Adeona completes 50 percent enrollment partly 2 CopperProof-2 research of oral zinc cysteine for Alzheimer’s Disease Adeona Pharmaceuticals, Inc. announced the completion of 50 percent enrollment partly 2 of its medical study, A Potential, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Planning in Alzheimer’s Disease . The CopperProof-2 study represents the initial controlled clinical study of oral zinc cysteine for the nutritional administration of Alzheimer’s disease and slight cognitive impairment. Subjects are randomized on a 50:50 basis to get either Zinthionein ZC or coordinating placebo. After 3 and 6 months on scientific trial materials, serum measurements of zinc and copper are used, and any adjustments in cognitive function using regular clinical tests used in Alzheimer’s disease and moderate cognitive impairment are documented.Acid reflux 3. Bloating 4. Coughing 5. Chest pain that may travel to the relative back, arms and jaw 6. Lack of appetite 7. Flatulence and Gas 8. Nausea and Vomiting 9. Sudden discomfort in the stomach 10. Heartburn that occurs about half an hour after eating and this pain are certain to get worse when the patient lies straight down or bends over 11. Generally, pain caused by this condition shall get eased when antacids are used, when drinking water and when standing up 12. Gastric ulcers 13. Weight loss 14. Ache in the ear 15. When the reflux turns out to be a tooth decay there will be hoarseness in the tone of voice, sore throat shall be encounter and there are likelihood of tooth decay as well 16. The patients could also feel as if the throat is usually constricted and closed up 17. When there is definitely gastric ulcer problem, it is a symptom of acidity 18.